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ABSTRACT
Rapid sequence induction and intubation (RSII) is the preferred method of tracheal intubation in emergen-
cy situations for patients presenting with a full stomach. The aim of RSII is to intubate the trachea within 
60 seconds, without having to use bag-valve-mask ventilation to avoid air insufflation into the stomach. 
After preoxygenation and while cricoid pressure is applied, an induction dose of intravenous anaesthetic 
agent is administered and rapidly followed by a fast-acting muscle relaxant, and after 60 seconds tracheal 
intubation is performed. 
Preoxygention increases apnoea tolerance. This is particularly important for infants and young children, 
and in patients who are in critical condition, obese or pregnant. Cricoid pressure (the Sellick manouver) is 
recommended to prevent regurgitation of the gastric contents to the throat. 
Propofol or thiopental are routinely used for induction. Ketamine or etomidate may be used if propofol or 
thiopental administration is contraindicated. Succinylcholine or rocuronium are used to facilitate tracheal 
intubation. Poor jaw relaxation, patient resistance to a laryngoscope, closed or closing vocal cords, vigorous 
limb movements or sustained coughing after tube insertion are not clinically acceptable.
Modified rapid sequence induction, used in patients at risk of rapid development of hypoxaemia, allows 
gentle positive pressure ventilation after administration of the induction agent and muscle relaxant, but 
before the tracheal intubation.
If the attempt of intubation fails, sugammadex, 16 mg/kg body weight is recommended for the immediate 
reversal of the neuromuscular block produced by rocuronium, but not for other muscle relaxants. 
KEY WORDS: intubation endotracheal, intubation methods, muscle relaxants depolarizing, muscle relaxants 
non-depolarizing, cyclodextrines 
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INTRODUCTION
Endotracheal intubation is the cornerstone of air-
way management. It provides maximal protection 
against aspiration of the gastric content to the lungs 
and allows for positive pressure ventilation with 
a higher airway pressures than during ventilation via 
a facemask or the supraglottic airway. Therefore, it 
is considered to be the definitive method of securing 
the airway. 
Indications for tracheal intubation in emergency 
situation include:
 — Inability to maintain the patency of the upper air-
way;
 — Inability to protect the airway against aspiration;
 — Respiratory failure;
 — Traumatic brain injury, Glasgow Coma Scale < 9;
 — The expected worsening of the patient’s condi-
tion that will eventually lead to respiratory fail-
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ure, the inability to maintain airway patency or 
protection against aspiration;
 — Other indications.
DEFINITION 
Rapid sequence induction and intubation (RSII) is the 
preferred method of tracheal intubation in emergency 
situations. The aim of RSII is to intubate the trachea 
without having to use bag-valve-mask (BVM) ventila-
tion. Positive pressure ventilation is avoided until the 
airway is secured with an endotracheal tube, unless at-
tempts at intubation are unsuccessful, or desaturation 
occurs. Apnoea may be poorly tolerated by patients 
with compromised respiratory status i.e. patients in 
critical state, obese or pregnant, or by patients with 
a high baseline oxygen requirement, or young children. 
INDICATIONS AND CONTRAINDICATIONS
Avoiding of air insufflation into the stomach is par-
ticularly important for patients who have not fasted 
(“full stomach”) and who are therefore at a greater 
risk of vomiting and aspiration of the gastric content 
to the lungs. 
It must be noted RSII is not indicated in uncon-
scious and apnoeic patients when immediate posi-
tive pressure ventilation using a self-inflating bag and 
facemask (BVM) and endotracheal intubation without 
any induction drugs or muscle relaxants is indicated, 
as stated in the resuscitation guidelines [1]. 
RSII may be also a bad choice if difficult intuba-
tion is anticipated. In this case the “difficult airway 
protocol” [2], with some modifications for a full 
stomach, may be more appropriate.
PERFORMING RSII 
The patient’s airway should is assessed in order 
to predict the difficulty of intubation. An ECG, 
pulse-oxymeter and blood pressure cuff should be 
employed. The equipment for the intubation, in-
cluding laryngoscopes, endotracheal tubes, guide-
wires and suction must be selected and checked. 
Intravenous access must be obtained and drugs for 
the induction prepared in syringes. 
After adequate preoxygenation and while cri-
coid pressure is being applied, an induction dose of 
intravenous anaesthetic agent is administered and 
rapidly followed by a fast-acting muscle relaxant. 
The trachea is intubated without any attempts of 
positive pressure ventilation, all the time maintain-
ing the cricoid pressure. The objective is to achieve 
optimal intubating conditions rapidly and to min-
imize the time between the loss of consciousness 
and securing the airway with a cuffed endotrache-
al tube.
Cricoid pressure (the Sellick manouver) is a key 
component of RSII. It involves the application of 
pressure at the cricoid ring to occlude the upper 
oesophagus, thereby preventing regurgitation of 
gastric content into the pharynx [3]. Air entry into 
the stomach is prevented as long as a patent air-
way is maintained [4] The effectiveness of cricoid 
pressure is due to occlusion of the hypopharynx [5], 
therefore the position of the oesophagus, which 
may have a tendency to move rightwards, seems to 
be irrelevant. The recommended force is 10 new-
tons is a conscious patient, increased to 30 N after 
loss of consciousness [6]. Although properly ap-
plied cricoid pressure is effective in reducing the 
risk of aspiration, excessive force can obstruct the 
subglottic airway and interfere with mask ventila-
tion or successful tracheal intubation, worsening 
laryngeal visualization during a direct laryngoscopy, 
potentially extending the time to intubation and 
increasing the risk of pulmonary aspiration. 
Using cricoid pressure is encouraged for RSII. If 
glottic visualization proves difficult, it can be easily 
released [7]. Using a videolaryngoscope seems to 
facilitate the selection of the optimal cricoid pres-
sure. 
Preoxygenation — a period of spontaneous 
breathing with 100% oxygen through a tightly fit-
ted facemask in order to replace nitrogen in the 
lungs with oxygen before the administration of 
an induction agent and muscle relaxant, is recom-
mended before the induction of general anaesthe-
sia [7], as difficulty with airway management may 
occur unexpectedly. RRSI should also be preceded 
by preoxygenation whenever possible. Preoxygena-
tion requires 3 minutes of normal breathing [7, 8] 
or a few very deep breaths (with vital capacity). 
Although the latter method may be more appro-
priate in an emergency, it requires the patient’s 
cooperation. Preoxygention increases the apnoea 
tolerance, and gives more time to expose the larynx 
and place the tube in the trachea. It is particularly 
important for infants and young children who are 
less tolerant to apnoea due to increased oxygen 
consumption, and in patients who are in a critical 
condition, obese or pregnant. 
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vocal cord relaxation. Scoring of the intubating con-
ditions according to the Good Clinical Practice in 
Anaesthesia Guidelines [9] is presented in Table 2. 
Intubating conditions are rated excellent if all 
qualities are excellent; good  — if all qualities are 
excellent or good, and poor if  any quality is poor. 
Excellent and good intubating conditions are sum-
marised as clinically acceptable conditions. Poor jaw 
relaxation, patient resistance to a laryngoscope, 
closed or closing vocal cords, vigorous movements 
of the limbs or sustained coughing after the tube 
insertion are considered clinically not acceptable [9]. 
From its introduction the 1950s until recently, 
succinylcholine was the drug of choice in order to 
facilitate tracheal intubation. In recent years, howev-
er, it has largely been replaced by rocuronium. 
Succinylcholine is still popular in emergency 
medicine as it has the fastest onset and shortest 
duration of action of all muscle relaxants, while ex-
cellent-to-good intubating conditions are usually 
achieved after 60 s. Increasing age is associated with 
a slower onset of the neuromuscular block. After 
administration of 1.0 mg/kg body weight of succi-
nylcholine, the onset time (the time from injection to 
the maximum effect) is 58 ± 7 s in infants 1–3 years 
old, and 95 ± 7 s in 60–80 year-old patients, respec-
DRUGS USED FOR RSII 
Induction drugs 
RSII involves administration of an induction agent 
(i.e. propofol, thiopental, ketamine, etomidate) to 
render the patient unconscious, and a fast-acting 
muscle relaxant to achieve muscle relaxation and 
tracheal intubation within 60 seconds. It requires 
experienced, well trained medical staff (Tab. 1).
The dose of propofol or thiopental must be re-
duced in patients with hypovolemia, since with the 
“regular” adult dose, its concentration in the blood 
is higher than intended, hence the risk of circulatory 
collapse. 
Ketamine is the drug of choice for patients in 
shock. Although its onset time is longer, which means 
that it takes longer from the injection to the loss of 
consciousness, blood pressure is maintained, as well 
as airway patency and spontaneous breathing. 
Etomidate is the drug of choice for the patients 
with heart failure. Its onset time is long, with invol-
untary movements resembling seizures. 
Muscle relaxants 
Apart from the anatomy, intubating conditions de-
pend on the masseter relaxation (jaw opening) and 
Table 1. Choosing drugs for induction
Agent “Typical adult” dose (mg.kg-1) Onset time to LOC* Main indications Contraindications 
Propofol 2 Short Standard RSII Shock 
Thiopental 5 Short Standard RSII Shock 
Ketamine 1–2 Long Shock Standard RSII 
Etomidate 0.2–0.3 Long Heart failure Standard RSII 
*LOC — loss of consciousness 




Clinically acceptable  Clinically not acceptable
Variable Excellent Good Poor
Laryngoscopy      
   Jaw relaxation Relaxed Not fully Poor
   Resistance to laryngoscope None Slight Active
Vocal cords      
   Position Abducted Intermediate Closed
   Movement None Moving Closing
Reaction to tube insertion or cuff inflation      
   Movement of limbs None Slight Vigorous
   Coughing None Slight Sustained
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tively [10]. The time to regular spontaneous breath-
ing is approx. 6 min. — which is too long, if the pa-
tient cannot be ventilated, while there are no drugs 
to speed up the return of spontaneous breathing. 
The time to or 90% recovery of the muscle strength 
is approx. 10 minutes [11]. 
The mechanism of action of succinylcholine is 
different from all other currently used muscle relax-
ants. Succinylcholine is called a “depolarizing” muscle 
relaxant, since its action resembles that of the natu-
ral mediator, acetylcholine. Succinylcholine combines 
with the acetylcholine receptor, opening the ion chan-
nels, which means depolarization of the neuromuscu-
lar junction and muscle fibres, and Na+ and K+ ion 
shift between the extracellular and intracellular fluid. 
Muscle relaxation is preceded by uncoordinated con-
tractions of skeletal muscles — fasciculations, which 
appear first on the eyelids, soon afterwards on the 
neck (m. platysma), then in the chest muscles, abdo-
men, and the extremities. Fasciculations may produce 
muscle pain, possibly secondary to muscle damage 
produced by the unsynchronized contractions of mus-
cle fibres just before the onset of paralysis. Although 
administration of a small dose of a non-depolarizing 
muscle relaxant (“precurarization”) prevents fascic-
ulations, and the muscle pain from succinylocholine 
is at least attenuated, it stops the swallowing reflex 
and may increase the risk of aspiration if regurgitation 
occurs in spite of cricoid pressure. 
Succinylcholine administration may temporar-
ily increase the masseter tone both in adults [12] 
and in children [13]. In patients with neuromus-
cular diseases, hemiplegia or paraplegia resulting 
from a cerebrovascular accident or trauma, muscu-
lar dystrophies, Guillain-Barré syndrome, extensive 
burns and severe injuries succinylcholine may cause 
significant hyperkaliemia, resulting in arrhythmia 
or cardiac arrest. Significant hyperkaliemia usually 
does not occur until several days after the injury. In 
the absence of infection or persistent degeneration 
of the tissue, patients are susceptible to hyperka-
liemic response probably for at least 60 days after 
a massive trauma. 
Succinylcholine usually causes an increase in 
intraocular pressure (IOP [14]). As long lasting 
(1–2 min) contracture of the extraocular muscles 
pulls the eye against the orbit, succinylcholine should 
not be given to patients with open eye injuries [15]. 
It also has the potential to increase intracranial pres-
sure (ICP [16]). In humans under light anaesthesia, 
ICP goes up by approx. 5 mm Hg [17].
A rare, but life threatening complication of suc-
cinylcholine is malignant hyperthermia. This may 
occur in people with muscle dystrophies — a rare 
inherited muscle abnormality. As most cases occur 
in children, mainly boys, who are unaware of the 
condition, it is advised to limit using succinylcholine 
in children. With prompt treatment using dantro-
lene, malignant hyperthermia usually resolves itself 
within 12–24 h [18].
In the recent years, succinylcholine has been 
largely replaced by rocuronium, which is a non-de-
polarizing, or competitive muscle relaxant. Rocuro-
nium combines with the acetylcholine receptor at 
the neuromuscular junction, but does not activate 
it, which means that there is no membrane depo-
larization, no ion shift, no fasciculations, no muscle 
damage, and no risk related to hyperkaliemia or ma-
lignant hyperthermia. For RSII, 1.0 mg rocuronium 
bromide per kg body weight is recommended for 
facilitating tracheal intubation [19]. Adequate intu-
bation conditions are established within 60 seconds 
in nearly all (> 90%) patients, and rated “excellent” 
in 70% of patients [19]. Increasing the intubation 
dose to 1.2 mg/kg body weight increases the prob-
ability of successful intubation at 60 s [20]. It should 
be noted that the rocuronium dose recommended 
for the RSII is higher than the dose of 0.6 used 
during routine anaesthesia. Conditions associated 
with prolonged circulation time such as cardiovas-
cular diseases, old age and an generalized oedema 
resulting in an increased volume of distribution may 
contribute to a slower onset of the effect. When 
used in overweight or obese patients (defined as 
patients with a body weight of 30% or more above 
ideal body weight) doses should be reduced, taking 
into account a lean body mass [21]. 
FAILED INTUBATION AND REVERSAL OF THE 
NEUROMUSCULAR BLOCK PRODUCED BY 
ROCURONIUM 
The clinical duration of the neuromuscular block 
after 1.0 mg/kg body weight of rocuronium is much 
longer than that of succinylcholine. The time from 
the administration of 1.06 mg/kg body weight of 
rocuronium to the first detectable symptoms of the 
recovery of neuromuscular transmission is 46 min-
utes. A few minutes later, muscle strength can be 
restored with an acetylcholinesterase inhibitor, ne-
ostigmine. If neostigmine is administered after the 
onset of spontaneous recovery of the neuromus-
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cular transmission, the recovery of muscle strength 
takes 9–13 minutes [22]. However, if neostigmine 
is administered too early, before the onset of the 
spontaneous recovery, it will be inefficient. There-
fore it cannot be used for the rapid restoration of 
spontaneous breathing after a failed attempt at 
intubation. Sugammadex (Bridion, N.V. Organon, 
The Netherlands) is a modern reversal agent offer-
ing the possibility of rapidly reversing the profound 
neuromuscular block produced by rocuronium. 
Sugammadex is the first selective relaxant binding 
agent. It has no effect on acetylcholinesterases and 
its mechanism of action is completely different from 
neostigmine. Sugammadex molecules encapsulate 
rocuronium molecules in plasma and in the extracel-
lular fluid forming an inactive complex. This creates 
a concentration gradient between the rocuronium 
concentration in the neuromuscular junction and 
plasma and rapid diffusion of the muscle relaxant 
from the acetylcholine receptors to the extracellular 
fluid and plasma. This restores neuromuscular trans-
mission and muscle strength. The inactive complex 
of rocuronium and sugammadex is excreted by the 
kidneys [23].
For the immediate reversal of a rocuronium- 
induced neuromuscular block, a dose of 
16 mg/kg body weight of sugammadex is recom-
mended — a dose many times higher than that 
routinely used at the end of anaesthesia. It is admin-
istered as a single bolus injection, given rapidly into 
an existing venous line. When 16 mg/kg body weight 
of sugammadex is given 3 minutes after a bolus dose 
of 1.2 mg of rocuronium, the median recovery time 
to the moment when the patient regains muscle 
strength is approximately 1.5 minutes. In obese pa-
tients, the dose of sugammadex should be based on 
actual body weight. Immediate reversal in children 
and adolescents has not been investigated and is 
therefore not recommended by the manufacturer 
until further data becomes available. The decision to 
use sugammadex “off-label” in a paediatric patient is 
left at the discretion of the clinician, who must weigh 
the potential benefits and risks [24]. 
Sugammadex is not recommended for immedi-
ate reversal of the neuromuscular block produced 
by succinylcholine or any other muscle relaxants, 
vecuronium included. 
On rare occasions, marked bradycardia, some-
times resulting in cardiac arrest, has been observed 
within minutes after sugammadex administration. 
Monitoring of haemodynamic changes, and atro-
pine administration, if clinically indicated, are there-
fore recommended. 
It must be noted that muscle relaxants do not 
produce unconsciousness or pain relief. As muscle 
paralysis without anaesthesia causes considerable 
psychological distress which the patient is unable to 
communicate, administration of the muscle relax-
ants to a conscious patient is contraindicated. 
Latency 
During RSII, the injection site important. If the in-
duction drugs and muscle relaxant are administered 
to a small peripheral vein, especially in the lower 
extremities, the time required to reach the brain 
and neuromuscular junction is much longer than 
after the administration to larger veins, which is 
equivalent to a long latency. If small peripheral veins 
must be used, the drug should be flushed with an 
appropriate volume of a fluid, usually 0.9% saline. 
Latency will also be long in patients with slow cir-
culation, i.e. those with heart failure or hypothermia. 
MODIFIED RAPID SEQUENCE INDUCTION 
Modified rapid sequence induction consists of pre-
oxygenation, the application of cricoid pressure, and 
gentle positive pressure ventilation after administra-
tion of the induction agent and muscle relaxant, 
but before the tracheal intubation. Indications for 
this technique include patients at risk of rapid de-
velopment of hypoxaemia (e.g., in those critically ill, 
morbidly obese or pregnant), in emergency situa-
tions where preoxygenation cannot be satisfactorily 
completed or when a longer time to achieve tra-
cheal intubation is anticipated. Although the effect 
of positive pressure ventilation with the application 
of  cricoid pressure  in terms of gastric insufflation of 
air is not definitively known, gentle positive pressure 
ventilation with an inspiratory pressure < 20 cm H2O 
in combination with cricoid pressure may be accept-
able in these clinical scenarios [25]. Positive pressure 
ventilation via a face mask may also be provided be-
fore and after administration of a muscle relaxant for 
patients unable to tolerate the brief period of apnoea 
associated with RSII. 
To summarize, rapid sequence induction and 
intubation is the method of choice for emergency 
intubation. It requires careful planning and skilful 
execution. In the case of failed intubation, sugam-
madex may be used to restore muscle strength and 
spontaneous breathing. 
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